Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtrer
Plus de filtres








Gamme d'année
1.
National Journal of Andrology ; (12): 260-262, 2003.
Article de Chinois | WPRIM | ID: wpr-238051

RÉSUMÉ

<p><b>OBJECTIVES</b>To further discuss the method of evaluating curative effect on erectile dysfunction(ED).</p><p><b>METHODS</b>Clinical trials(Phase II) of sildenafil and phentolamine were both 8-week-long, randomized, double-blind and placebo-controlled. Not only the curative effect between each treatment group and placebo group but also between the treatment groups were compared. The dosage of sildenafil and phentolamine was respectively 50-100 mg and 40 mg.</p><p><b>RESULTS</b>Efficiency, success rate of sexual intercourse and general curative effect in sildenafil and phentolamine groups were respectively 79.17%, 75.00%, 83.33% and 52.38%, 85.71%, 52.38%. The result revealed a statistically significant (P < 0.05) improvement over placebo. But no obvious differences were shown between the two treatment groups(P > 0.05).</p><p><b>CONCLUSIONS</b>Most assessments of curative effect of ED drugs come from questionnaires answered subjectively by patients. The Lack of objective assessment criteria way lead to the non-conformity between trial results and clinical practices. So the curative effect of drugs shall be assessed more accurately and from more perspectives.</p>


Sujet(s)
Humains , Mâle , Antagonistes alpha-adrénergiques , Utilisations thérapeutiques , Méthode en double aveugle , Dysfonctionnement érectile , Traitement médicamenteux , Phentolamine , Utilisations thérapeutiques , Pipérazines , Utilisations thérapeutiques , Purines , Citrate de sildénafil , Sulfones , Enquêtes et questionnaires , Résultat thérapeutique , Vasodilatateurs , Utilisations thérapeutiques
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE